logo
#

Latest news with #Quince

I Island Hopped in Greece for 2 Weeks—and I Didn't Check a Bag Thanks to These 15 Packable Fashion Pieces
I Island Hopped in Greece for 2 Weeks—and I Didn't Check a Bag Thanks to These 15 Packable Fashion Pieces

Travel + Leisure

time12 hours ago

  • Travel + Leisure

I Island Hopped in Greece for 2 Weeks—and I Didn't Check a Bag Thanks to These 15 Packable Fashion Pieces

Greece will always hold a special place in my heart. It was the very first international destination my (now) husband and I visited, nearly a decade ago—and, just last year, it's where we went on our honeymoon. On the former trip, we visited Athens, Santorini, and Crete; on the latter, we spent two gorgeous weeks island hopping from Paros to Milos and then on to Sifnos. Visiting three Greek locales requires a foolproof packing list to ensure that every activity, terrain, and climate is accounted for. I also highly recommend sticking to a carry-on bag if you can (at least, that's my preference, especially when navigating the narrow streets of Greece). Below, explore the 15 non-negotiable travel clothing and accessory essentials I relied on that deserve a spot in your suitcase when visiting the Greek Isles this summer. A solid button-up blouse — ideally in linen, cotton, or silk — is at the top of my summer vacay list. I personally packed this Quince Washable Stretch Silk Blouse on my trip, and it's one I often take on any vacation because it's so versatile and easy to wear. Not only is it super lightweight and breathable (a must in a warm climate like Greece), but it also takes up virtually no space in your suitcase. Plus, this top is the ultimate clothing chameleon: Pair it with casual shorts and sneakers, wear it with a skirt and heeled sandals, or toss it over your swimsuit as a classy cover-up. I personally own it in white (and find that's the most versatile), but it also comes in a number of other lovely colors. For days of visiting beaches or exploring Cycladic towns, I always reach for an easy-to-wear pair of shorts. On extra warm days, I'm a fan of wearing a loose-fitting linen option like these Quince European Linen Shorts, which I packed for my last trip to Greece. I own them in black, but they're also available in a number of pretty colors and patterns to suit any preference. For something a bit more structured, you could opt for these classic Madewell Bermuda Shorts. Either of these neutral options could easily mix and match with any of the tops in your luggage, so there's no need to pack more than one pair in your carry-on. A gorgeous pair of linen pants is a must for any Greek vacation. I've been obsessed with the Australian fashion brand Dissh's elastic linen trousers for travel, but if you're looking for something at a lower price point, you can't go wrong with this $40 wide-leg pair from Halara. Whichever route you choose, you'll have a wrinkle-free, space-saving option that goes with everything, whether you're exploring the city or hanging by the beach. Let's be real, when we're packing for vacation—especially somewhere as scenic as Greece—you're going to want to bring at least one standout, picture-worthy outfit. My personal favorite: a statement dress, like this stunning floral one from ASTR the Label. It's worth noting that while a maxi dress may take up a bit more space than its shorter counterpart, it's a one-garment outfit, which is ultimately a space-saver. Any dress with a vibrant pattern or unique design will make you feel like an ethereal Greek goddess, in my opinion. However, you can still go bold with something understated like this smocked maxi dress from Amazon-loved brand PrettyGarden. Personally, I packed this Favorite Daughter linen dress on my last trip to Greece, and it was a chic hero piece for my vacation wardrobe. On a trip to Greece, you're going to need sandals that are well-suited for wearing to the beach, walking along cobblestone paths, and maybe even hiking down into secluded coves (yes, this came up while I was in Milos). For that reason, I'd recommend packing a pair of sandals that are well-suited for any active adventure, like the Teva Hurricanes or Merrell Speedfusions. When I'm headed to a coastal destination like Greece, I love packing a simple dress like Dissh's Lotus Linen Dress that I can toss on with a pair of sneakers and head out for a day exploring, or slip over my swimsuit before heading to the sea. It embodies that effortless Greek style, hardly takes up any packing space, and creates a complete outfit with just one easy-to-wear piece. For something a bit more budget-friendly, I found this linen dress at Amazon that achieves the same vibe at a fraction of the price. $90 at Amazon $90 at Nordstrom While you'll most likely spend your days ambling around Greece in a pair of sandals, it's always a good idea to bring at least one pair of closed-toed shoes on any trip (especially for when the temps drop at night). For the purposes of a Greek vacation, I'd keep it simple with a pair of white sneakers. On our trip, I opted for classic Reebok Club Cs, whereas my husband packed a pair of white and navy Nike Killshot leather shoes. Pro tip: I'd wear these on the plane to save space in your bag. A trip to the Greek Isles means plenty of time swimming in pools and the sea; therefore, a chic swimsuit is a must. For lounging by the pool at Andronis Minois Paros, I packed the LSpace Hazel Ribbed Bikini Top and matching bottoms, which I adored because both are super comfortable, offer a decent amount of coverage for a two-piece, and also the white piping gives the classic black bikini a more unique design. However, if you're not a fan of bikinis, then check out the Baewatch Colorblock Trim Ribbed One-piece Swimsuit, which has a similar style, or Cupshe's ultra-flattering one-piece that's only $40 at Amazon. Hopefully, your Greek isle itinerary includes plenty of time at the beach and on the water, which means your valuables might be in danger of getting wet or sandy. That's where a waterproof bag like this one from Amazon (which has thousands of five-star reviews) can come in handy. Simply slip in your phone and then enjoy the Aegean Sea stress-free. While you can get away with dressing pretty casual in Greece, I like to have at least one pair of sandals that feel elevated enough to wear to a nicer dinner, which is why I packed the Nisolo Platform Sandals for my trip and absolutely loved wearing them. Not only do they have incredible support for long days on your feet, but they also work just as well with a pair of shorts as they do with a more elegant dress. $198 $158 at Even though Greece gets quite warm in the summer, temperatures can drop at night, especially if you're visiting one of the windier islands like Milos. I recommend packing at least one jacket, like this insulated option from Vuori, which is one of my go-tos for just about any trip—it features a lightweight yet warm construction and neutral colorway that goes with everything. Speaking of layers, a cardigan is another great option for when the temperatures dip come nightfall. A few of my favorites include the Jenni Kayne Murphy Cardigan, which you can wear on its own as a sweater or draped over a dress (it came in handy when we ferried over to Sifnos, where we experienced the incredible cuisine and meandered about the breezy cliffside towns). Over at Amazon, you can achieve the same look with the Verdusa cropped cardigan ($30) or the Amazon Essentials V-neck Cardigan Sweater that's on sale for $17. One of my favorite accessories to pack is a silk scarf. It takes up virtually no room in your luggage, but can completely transform an outfit by adding a splash of color to an otherwise simple ensemble. Most of the scarves in my collection are either passed down from my mom or sourced vintage, but I spotted a couple that would be a great addition to anyone's collection, like this pretty blue and white option from Kurt Geiger, bold printed Nordstrom one, or even this silky floral-adorned option from Amazon that's on sale for $13. An iconically shaped pair of sunglasses is a great space-saving accessory that can elevate your entire outfit while also protecting your eyes. I packed these fun cat-eye sunglasses from Maui Jim for my last trip to Greece, and I love these sunnies for their vintage style, along with the fact that they feature polarized lenses, a must when walking around Greece or relaxing by the pool at our sophisticated yet understated hotel, Verina Astra. For a lower price point option, I'd recommend Goodr's no-slip, no-bounce Circle G shades for $25. When I'm enjoying a dreamy adventure abroad, I want my sleepwear to rise to the occasion. I am currently obsessed with the silky-smooth pajama sets from Eberjey, which feel truly luxurious on my skin. The breathable fabric also stays fresh and clean after multiple wears, reducing the need to pack excessive sleepwear. My other favorite summery shorts sets (both on vacation and at home): Cozy Earth's bamboo PJs, Quince's 100% European Linen PJ set, and Old Navy's $40 Poplin Pajama Short Set. Another small accessory that can make a big impact: jewelry, of course. For a Grecian vacation, I love this Pavoi coin necklace at Amazon, which only costs $17, or this layered set from Aritzan Joyeria, both of which help upgrade even a simple outfit. I'm also a fan of these lovely Gorjana braided earrings for the same reason. Love a great deal? Sign up for our T+L Recommends newsletter and we'll send you our favorite travel products each week.

40 Best Breezy Linen Clothing Finds to Stay Cool This Summer—J.Crew, Quince, Gap, and More Are Up to 65% Off
40 Best Breezy Linen Clothing Finds to Stay Cool This Summer—J.Crew, Quince, Gap, and More Are Up to 65% Off

Travel + Leisure

time2 days ago

  • Lifestyle
  • Travel + Leisure

40 Best Breezy Linen Clothing Finds to Stay Cool This Summer—J.Crew, Quince, Gap, and More Are Up to 65% Off

Rejoice: It's officially linen season! The breezy fabric is one of my favorite fashion hacks for warm weather. It's as comfy as pajamas, with an elevated appearance that can suit any occasion. That's why it's a go-to style for every summer vacation. If your summer wardrobe needs a refresh, consider adding airy linen pieces to your closet. I found the most stylish linen pants, shorts, summer dresses, and more. Keep reading to shop the 40 best linen clothing finds from Quince, Gap, and more top retailers—up to 65 percent off. Linen pants are timeless, so if you invest in a quality pair, they'll be a go-to style for near-countless vacations. Whether you prefer flowy pants, pleated trousers, or a cropped pair, the following linen styles will keep you comfy and stylish all summer long. I've found some of the most stylish shorts on the market, all in breathable linen fabrics that will help you beat the heat. Shop nautical striped shorts, Abercrombie's mid-rise mini pair, and Everlane's work-ready pleated style—plus even more covetable pieces from $16. It doesn't get breezier than a linen dress. The following mini, midi, and maxi styles are perfect for hot summer days. If you're searching for a sophisticated option for dressier occasions, check out the Madewell Scoopneck Sleeveless Midi Dress. Prefer a beachier look? The Abercrombie & Fitch V-neck Linen-blend Mini Dress is a great option. For a dress that can do it all, check out the now-$60 Linen Utility Shirtdress. Plus, shop even more summery dresses below. When it comes to linen shirts, the possibilities are endless. We've found nearly every silhouette, including flutter-sleeve blouses, cropped tanks, button-down shirts, and more. Plus, shop my personal favorite, the Gap Linen Tie-front Shirt, for under $40 today. These linen skirts can be dressed up or down, so they're versatile enough to earn a spot in your travel capsule wardrobe. Shop colorful options like the Gap Linen-blend Mini Skort and patterned Abercrombie & Fitch Mid-rise Linen-blend Maxi Skirt, plus neutral staples like the Gap Linen-blend Midi Skirt and Open Edit Linen-blend Wrap Skort. These top styles include skorts, mini skorts, and maxi styles starting at $10. Love a great deal? Sign up for our T+L Recommends newsletter and we'll send you our favorite travel products each week.

Quince Therapeutics Announces Closing of Up to $22 Million Private Placement of Securities
Quince Therapeutics Announces Closing of Up to $22 Million Private Placement of Securities

Business Wire

time3 days ago

  • Business
  • Business Wire

Quince Therapeutics Announces Closing of Up to $22 Million Private Placement of Securities

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Quince Therapeutics, Inc. (Nasdaq: QNCX) ('Quince' or the 'Company'), a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases, today announced the closing of its previously announced sale and issuance to certain institutional and accredited investors, of its common stock (or pre-funded warrants in lieu thereof), and accompanying common warrants ('Warrants') that resulted in approximately $11.5 million in upfront proceeds and potential additional proceeds of up to $10.4 million if the accompanying Warrants are exercised in full for cash, before deducting placement agent fees and other private placement expenses. The private placement priced at a premium and was led by healthcare-focused institutional investor Nantahala Capital with participation from existing Quince stockholders including ADAR1 Capital Management, along with members of Quince's senior management. Dirk Thye, M.D., Quince's Chief Executive Officer and Chief Medical Officer, said, 'We are pleased to secure additional financing that allows us to complete enrollment of our pivotal Phase 3 NEAT clinical trial and extend our cash runway beyond topline results. This transaction reflects a significant commitment from high caliber healthcare investors who believe in our technology platform and Phase 3 asset, eDSP. Success in our lead indication of Ataxia-Telangiectasia (A-T) would demonstrate our ability to deliver corticosteroid efficacy without toxicity and would expand opportunities for pursuing additional indications for both rare and non-rare diseases.' Quince intends to use the net proceeds of this offering for working capital and general corporate purposes, including funding the ongoing enrollment of the Company's pivotal Phase 3 NEAT (N eurological E ffects of e DSP on Subjects with A - T; NCT06193200 / IEDAT-04-2022) clinical trial in A-T, research and development expenses, general and administrative expenses and capital expenditures. The net upfront proceeds from the private placement, combined with Quince's current cash, cash equivalents, and short-term investments of $31.6 million as of March 31, 2025, are expected to fund the Company's operations into the second quarter of 2026, or the second half of 2026 if the Warrants are exercised in full for cash. In addition, the Company expects to use proceeds to continue to expand and accelerate its development pipeline by funding new program expansion into Duchenne muscular dystrophy and other high priority rare disease indications for its lead asset eDSP. The Company continues to make meaningful progress in enrolling participants in its pivotal Phase 3 NEAT clinical trial. Key highlights to date include: A total of 95 participants have been enrolled, including 77 participants in the six to nine year-old primary analysis population and 18 participants aged 10 years or older. All 39 NEAT participants to date have elected to transition to the NEAT open label extension (OLE) study (NCT06664853 / IEDAT-04-2022). Participants who complete the full treatment period, complete study assessments, and provide informed consent are eligible to transition to the OLE study. Quince expects to report topline results from the Phase 3 NEAT clinical trial in the first quarter of 2026. Assuming positive study results, the Company plans to submit a New Drug Application to the U.S. Food and Drug Administration (FDA) in the second half of 2026. Quince was granted FDA Fast Track designation for the Company's eDSP System for the treatment of patients with A-T based on the potential for eDSP to address a high unmet medical need. NEAT is an international, multicenter, randomized, double-blind, placebo-controlled clinical trial to evaluate the neurological effects of Quince's lead asset, eDSP (dexamethasone sodium phosphate [DSP] encapsulated in autologous red blood cells; previously referred to as EryDex) in patients with A-T. Participants are randomized (1:1) between eDSP or placebo and treatment consists of six infusions scheduled once every 21 to 30 days. The primary efficacy endpoint will be measured by the change from baseline to last efficacy visit in the rescored modified International Cooperative Ataxia Rating Scale (RmICARS) compared to placebo. About the Private Placement At the closing, the Company issued to the investors an aggregate of 6,671,928 shares of common stock, 2,000,000 pre-funded warrants and accompanying Warrants to purchase an aggregate of 8,671,928 shares of common stock (or pre-funded warrants in lieu thereof), at a combined purchase price of $1.325 per share (or $1.324 per pre-funded warrant) and accompanying Warrant (representing a 10% premium over the $1.20 closing price per share of the Company's common stock on June 11, 2025). The accompanying Warrants have an exercise price of $1.20 per share and are exercisable immediately. The Warrants will expire five years from the date of issuance. Citizens Capital Markets acted as the lead placement agent for the private placement. Maxim Group LLC and Brookline Capital Markets, a division of Arcadia Securities, LLC, acted as co-placement agents for the private placement. The securities issued in connection with the private placement described above were offered in a private placement and were not registered under the Securities Act of 1933, as amended (the 'Securities Act'), or any state or other applicable jurisdictions' securities laws, and were not offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state or other jurisdictions' securities laws. This news release does not constitute an offer to sell or the solicitation of an offer to buy the securities described herein, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation, or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction. About Quince Therapeutics Quince Therapeutics, Inc. (Nasdaq: QNCX) is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. For more information on the Company and its latest news, visit and follow Quince on social media platforms LinkedIn, Facebook, X, and YouTube. Forward-looking Statements Statements made in this news release that are not statements of historical or current facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that statements in this news release regarding the receipt of additional gross proceeds if the accompanying Warrants are exercised in full; the achievement of positive clinical trial results and approval of the eDSP by the FDA; the Company's intended use of the proceeds from the private placement, including the expected funding of new program expansion into Duchenne muscular dystrophy and other high priority rare disease indications for its lead asset eDSP; the potential for expanded opportunities for pursuing additional indications for both rare and non-rare diseases if A-T is successful; the Company's expectation that the net proceeds from the closing of the private placement, combined with its current cash, cash equivalents and marketable securities, will fund its operating and capital expenditures into the second quarter of 2026, or the second half of 2026 if all Warrants are exercised for cash; and the Company's strategy, future operations, future financial position, projected expenses, expected timing and results of clinical trials, prospects, plans and objectives of management constitute forward-looking statements that involve risks and uncertainties, including, without limitation, risks and uncertainties related to: cost, timing, progress and results of the pivotal Phase 3 NEAT clinical trial in A-T indication and potential future trials in other indications; the Company's ability to obtain FDA approval and successfully commercialize its product candidate; the satisfaction of customary closing conditions related to the proposed private placement and the impact of general economic, industry or political conditions in the United States or internationally, the current or evolving effects of macroeconomic conditions, on Quince's business operations and activities. There can be no assurance that the Company will be able to complete the proposed private placement on acceptable terms, or at all. Quince's actual results, performance, or achievements could differ materially from those expressed or implied by the forward-looking statements as a result of a number of factors, including the risks discussed under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of Quince's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of its Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Quince undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise that occur after that date, except as required by law.

The Quince Travel Essentials I'm Packing This Summer
The Quince Travel Essentials I'm Packing This Summer

Condé Nast Traveler

time4 days ago

  • Condé Nast Traveler

The Quince Travel Essentials I'm Packing This Summer

I used to be a 'buy a new wardrobe every time I travel' kind of a gal. But a few years ago, I discovered the beauty of a capsule wardrobe—and my wallet and closet have thanked me ever since. I've stopped buying fast-fashion items as much as possible and began investing in pieces that will stick around with me for longer than a single season. One of the first things I noticed after making the switch from trendy clothes to timeless staples is that I rarely feel like I have nothing to wear, especially when I'm traveling. Whether I'm driving up north to Boston to catch a glimpse of its fleeting fall foliage or headed out East for a few days of summer sun in Montauk, I pack many of the same hero pieces time after time. As I continue to grow my capsule wardrobe, I'm always on the lookout for brands for who do basics really well. And lately, that's Quince. For those unfamiliar with the brand, its goal is to deliver high-quality, long-lasting products without the hefty price tags. The lower-than-usual price point is what first attracted to me to Quince; the brand is able to keep its prices lower than competitors thanks to its factory-direct model that cuts out the middlemen. The quality of the pieces have kept me coming back. From everyday tees and super-soft cardigans to lightweight linen and versatile dresses, Quince is full of great-for-travel pieces to wear this summer and the one after that. I've added some of Quince's bestsellers to my wardrobe and they've quickly become some of my hardest-working clothing items. The simple designs allow pieces to blend well in a variety of outfits and trip itineraries, while looking and feeling a touch more elevated than my other everyday basics. Below, I've rounded up some of the best Quince travel clothes to get you started—some I own, others are ones I have my eye on. All are the kind of goes-with-everything pieces you'll be reaching for on every trip this summer. Whether you're packing for a hot and humid vacation along the Amalfi coast or a wine-filled getaway in Napa Valley, Quince has you covered with the airy dresses, washable maxi skirts, and dreamy cardigans you'll keep reaching for. Keep scrolling for all of the recommendations or jump right to the section you're shopping for. Everyday tops Everyday tops are the foundation of every packing list. Essentials like Quince's perfect white tee and its crisp linen button-down can be worn with anything, from jeans and shorts to skirts. This airy button-down can even double as a pool cover-up in a pinch. Beyond the basics, linen vests and tube tops elevate any outfit without overdoing it. You can easily dress these tops up, or keep it simple with some linen pants and comfortable sandals. Breathable bottoms I try to stay away from chafe-prone denim shorts or mini skirts in the summertime. Instead I'm all about breathable bottoms: breezy maxi skirts, silky midis, and linen pants. Here are a few of my current favorites, including a white poplin maxi skirt that's begging to be worn on a trip to Greece. Quince's chic silk skirt really won me over—not only because it's washable, but because it can be tightly rolled and tucked away in a small crevice of my suitcase without taking up any space at all. It's lightweight enough for daytime strolls, but can be tossed on for dinner, too. And if you're after some of moisture-wicking linen pants, look no further than Quince's $40 pairs. Coastal sweaters Don't forget your coastal grandmother cardigan! Not only is a super-soft striped crewneck or cardigan quietly elegant, it's also practical. Even if you're headed somewhere warm, you'll want something lightweight that you can throw over your shoulder for evening walks along the water or inside a chilly restaurant. This is one of the categories Quince does best. I couldn't believe how soft its Mongolian Cashmere sweater was when I first got my hands on it. I lived in it last fall; it will be one of those better-with-age pieces I return to year after year. These cardigans are simple enough to wear all over this summer, from Santa Barbara to Southhampton. Vacation dresses In a dream world, my suitcase would be filled with statement vacation dresses. In my fast-fashion days, this is where I really had my fun. But that bold wear-it-once dress isn't doing you any favors—it's too memorable! Chic, sophisticated dresses stand out without trying too hard, and are easy to rewear again again. From morning strolls to hotel dinners, the best vacation dresses from Quince keep you looking polished and feeling comfortable even on long travel days. Dress them up with a kitten heel and a sleek clutch, or toss on a pair of flat sandals for a day of sightseeing in Florence. If you want something more unique, say for destination wedding or an engagement party, consider renting a fun dress from Nuuly or Rent the Runway instead of committing long-term. The 'it' bag Just when I think I've successfully stuffed all the clothes and shoes I need in my carry-on, I remember I need to pack a handbag. It's one of those sneakily bulky items I forget requires ample suitcase space. My trick is to pack only one (yes, one!) handbag that can take me from a casual poolside brunch to an elegant dinner with ease. Your best bet is a black leather shoulder bag that's polished enough for evening hours while still being relaxed enough for daytime. For something a little softer, this Cognac-colored bag can be worn as a crossbod by day and a cutesy shoulder bag by night. Both bags are nice and roomy, easily fitting all of your daily essentials (phone, wallet, portable fan, etc).

Quince Therapeutics Announces Pricing of Up to $22 Million Private Placement of Securities
Quince Therapeutics Announces Pricing of Up to $22 Million Private Placement of Securities

Yahoo

time12-06-2025

  • Business
  • Yahoo

Quince Therapeutics Announces Pricing of Up to $22 Million Private Placement of Securities

Financing to provide $11.5 million in upfront proceeds with up to an additional $10.4 million of proceeds assuming exercise in full of the warrants Financing priced at a premium to last close SOUTH SAN FRANCISCO, Calif., June 12, 2025--(BUSINESS WIRE)--Quince Therapeutics, Inc. (Nasdaq: QNCX) ("Quince" or the "Company"), a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases, today announced that it has entered into a securities purchase agreement with certain institutional and accredited investors to purchase shares of its common stock (or pre-funded warrants in lieu thereof), and accompanying common warrants ("Warrants") that is expected to result in approximately $11.5 million in upfront proceeds and potential additional proceeds of up to $10.4 million if the accompanying common warrants are exercised in full for cash, before deducting placement agent fees and other private placement expenses. The private placement is being led by healthcare-focused institutional investor Nantahala Capital with participation from existing Quince stockholders including ADAR1 Capital Management, along with members of Quince's senior management. Quince intends to use the net proceeds of this offering for working capital and general corporate purposes, including funding the ongoing enrollment of the Company's pivotal Phase 3 NEAT (Neurological Effects of eDSP on Subjects with A-T; NCT06193200/IEDAT-04-2022) clinical trial in Ataxia-Telangiectasia (A-T), research and development expenses, general and administrative expenses and capital expenditures. The net upfront proceeds from the private placement, combined with Quince's current cash, cash equivalents, and short-term investments are expected to fund the Company's operations into the second quarter of 2026, or the second half of 2026 if the Warrants are exercised in full for cash. At the closing, the Company will issue to the investors an aggregate of 8,671,928 shares of common stock (or pre-funded warrants in lieu thereof), along with accompanying Warrants to purchase an aggregate of 8,671,928 shares of common stock (or pre-funded warrants in lieu thereof), at a combined purchase price of $1.325 per share (or $1.324 per pre-funded warrant) and accompanying Warrant (representing a 10% premium over the $1.20 closing price per share of the Company's common stock). The accompanying Warrants have an exercise price of $1.20 per share and will become exercisable immediately. The Warrants will expire five years from the date of issuance. The private placement is expected to close during the week of June 16, 2025, subject to the satisfaction of customary closing conditions. Citizens Capital Markets is acting as the lead placement agent for the private placement. Maxim Group LLC and Brookline Capital Markets, a division of Arcadia Securities, LLC, are acting as co-placement agents for the private placement. The securities to be issued in connection with the private placement described above are being offered in a private placement and have not been registered under the Securities Act of 1933, as amended (the "Securities Act"), or any state or other applicable jurisdictions' securities laws, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state or other jurisdictions' securities laws. This news release does not constitute an offer to sell or the solicitation of an offer to buy the securities described herein, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation, or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction. About Quince Therapeutics Quince Therapeutics, Inc. (Nasdaq: QNCX) is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. For more information on the company and its latest news, visit Forward-looking Statements Statements made in this news release that are not statements of historical or current facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that statements in this news release regarding the expected closing of the private placement; the receipt of additional gross proceeds if the accompanying common warrants are exercised in full; the achievement of positive clinical trial results and approval of the eDSP by the FDA; the company's intended use of the proceeds from the private placement; the company's expectation that the net proceeds from the closing of the private placement, combined with its current cash, cash equivalents and marketable securities, will fund its operating and capital expenditures into the second quarter of 2026, or the second half of 2026, assuming all warrants are exercised for cash; and the company's strategy, future operations, future financial position, projected expenses, expected timing and results of clinical trials, prospects, plans and objectives of management constitute forward-looking statements that involve risks and uncertainties, including, without limitation, risks and uncertainties related to: cost, timing, progress and results of the pivotal Phase 3 NEAT clinical trial in A-T indication and potential future trials in other indications; the company's ability to obtain FDA approval and successfully commercialize its product candidate; the satisfaction of customary closing conditions related to the proposed private placement and the impact of general economic, industry or political conditions in the United States or internationally, the current or evolving effects of macroeconomic conditions, on Quince's business operations and activities. There can be no assurance that the company will be able to complete the proposed private placement on acceptable terms, or at all. Quince's actual results, performance, or achievements could differ materially from those expressed or implied by the forward-looking statements as a result of a number of factors, including the risks discussed under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of Quince's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of its Quarterly Reports on Form 10-Q and in the company's other filings with the SEC. Quince undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise that occur after that date, except as required by law. View source version on Contacts Media & Investor Contact: Stacy RoughanQuince Therapeutics, President, Corporate Communications & Investor Relationsir@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store